Success Story: Advancing Research on Aging Biomarkers and Therapeutic Targets: NIW Approval Secured for a Biomedical Science Researcher from Italy

Client’s Testimonial:

 

“I had a very positive experience with Chen Immigration Law. As a researcher from Italy navigating the U.S. immigration process, I found their guidance very clear. Their team was exceptionally fast in responding to every question, ensuring my I-140 petition was prepared fast and submitted without delay. My I-140 was approved smoothly. I highly recommend Chen Immigration to any researcher or scientist looking for an immigration firm.”

 


 

On September 25th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Biological Scientist in the field of Biomedical Science (Approval Notice).

 


 

General Field: Biomedical Science

 

Position at the Time of Case Filing: Biological Scientist

 

Country of Origin: Italy

 

State of Residence at the Time of Filing: Maryland

 

Approval Notice Date: September 25th, 2026

 

Processing Time: 11 months, 15 days (Premium Processing Requested)

 


 

Case Summary:

 

We are pleased to share the NIW approval of a biomedical science researcher whose work focuses on understanding the molecular mechanisms underlying aging and age-related diseases. The client’s proposed endeavor centers on identifying reliable biomarkers and therapeutic targets and advancing interventions that may support healthier aging and improved quality of life for older adults. At the time of filing, the client was employed as a Biological Scientist at a U.S. research institution, where she continued investigating molecular pathways associated with aging and cellular senescence.


Research with National Importance


The client’s research addresses the growing health burden associated with aging and age-related diseases. By identifying biological markers of aging and studying molecular pathways that may be targeted therapeutically, her work can contribute to the development of interventions that improve health outcomes among older adults. The petition further connected her endeavor to U.S. priorities involving aging research, age-related disease, biomarker discovery, and the development of treatments that may reduce healthcare and economic burdens associated with an aging population.


Academic Contributions and Recognition


At the time of filing, the client had documented her research in 24 peer-reviewed journal articles, including 5 first-authored papers, as well as 1 conference abstract and 1 book chapter. She had also contributed to a granted patent. Her published work had received 945 citations. The petition additionally documented her service as a peer reviewer for multiple scholarly journals, reflecting recognition of her expertise in biomedical science and aging research. 


The petition further demonstrated the significance of the client’s research through citation impact and independent use of her findings. One of her papers ranked among the top 1%, seven among the top 10%, and two among the top 20% most-cited Biology & Biochemistry articles for their respective years of publication. Independent researchers had also relied on her work in studies involving cellular senescence, aging biomarkers, therapeutic targets, and the development of strategies for age-related diseases, further demonstrating the influence of her research. 


Recognition from Experts


Experts in the field also recognized the broader public health and economic significance of the client’s research on aging and cellular senescence.


One expert noted:


“...[client]’s skillset is of undeniable benefit to our country’s effort to better understand, treat, and potentially cure diseases in which inflammation and senescence are detrimental. Her work is immensely helpful for advancing geriatric and regenerative medicine, improving not only public health, but also the United States economy.”


This assessment further supports the petition’s position that the client’s research has broader significance for aging-related healthcare, biomedical innovation, and U.S. public health. 


NIW Approval and Outlook


The I-140 NIW petition was filed on October 10th, 2025, later upgraded to Premium Processing, and approved on September 25th, 2026. The petition highlighted the client’s scientific training, scholarly record, citation impact, peer-review service, and demonstrated influence in biomedical science to establish that she was well positioned to continue advancing her proposed endeavor.


This outcome supports the client’s continued efforts to advance biomedical research that may improve health outcomes and quality of life for older adults.